Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.650
+0.050 (1.92%)
Apr 30, 2024, 3:36 PM EDT - Market open
Armata Pharmaceuticals Revenue
In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, a decrease of -17.77%. Revenue in the quarter ending December 31, 2023 was $1.53M with 45.39% year-over-year growth.
Revenue (ttm)
$4.53M
Revenue Growth
-17.77%
P/S Ratio
20.03
Revenue / Employee
$68,621
Employees
66
Market Cap
96.88M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.53M | -979.00K | -17.77% |
Dec 31, 2022 | 5.51M | 1.03M | 23.11% |
Dec 31, 2021 | 4.47M | 3.65M | 443.62% |
Dec 31, 2020 | 823.00K | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 115.00K | -145.00K | -55.77% |
Dec 31, 2016 | 260.00K | -215.00K | -45.26% |
Dec 31, 2015 | 475.00K | 66.00K | 16.14% |
Dec 31, 2014 | 409.00K | 328.00K | 404.94% |
Dec 31, 2013 | 81.00K | -583.00K | -87.80% |
Dec 31, 2012 | 664.00K | 544.00K | 453.33% |
Dec 31, 2011 | 120.00K | -8.60M | -98.62% |
Dec 31, 2008 | 8.72M | -1.61M | -15.62% |
Dec 31, 2007 | 10.33M | 468.00K | 4.74% |
Dec 31, 2006 | 9.86M | 2.99M | 43.50% |
Dec 31, 2005 | 6.87M | -2.78M | -28.78% |
Dec 31, 2004 | 9.65M | -4.42M | -31.41% |
Dec 31, 2003 | 14.07M | -5.26M | -27.21% |
Dec 31, 2002 | 19.33M | 453.00K | 2.40% |
Dec 31, 2001 | 18.88M | 7.48M | 65.57% |
Dec 31, 2000 | 11.40M | 4.56M | 66.52% |
Dec 31, 1999 | 6.85M | -662.25K | -8.82% |
Dec 31, 1998 | 7.51M | 6.18M | 465.71% |
Dec 31, 1997 | 1.33M | -926.59K | -41.11% |
Dec 31, 1996 | 2.25M | 1.41M | 167.57% |
Dec 31, 1995 | 842.46K | - | - |
Dec 31, 1994 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SHL Telemedicine | 57.08M |
Allurion Technologies | 53.47M |
Elutia | 24.75M |
Myomo | 19.24M |
Abeona Therapeutics | 3.50M |
BioXcel Therapeutics | 1.38M |
ARMP News
- 5 weeks ago - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit - PRNewsWire
- 5 months ago - Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference - PRNewsWire
- 6 months ago - Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023 - PRNewsWire
- 7 months ago - Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus - PRNewsWire
- 7 months ago - Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference - PRNewsWire